Cimpress NV
$ 81.18
2.53%
17 Apr - close price
- Market Cap 1,953,512,000 USD
- Current Price $ 81.18
- High / Low $ 82.81 / 79.16
- Stock P/E 80.80
- Book Value -21.74
- EPS 0.98
- Next Earning Report 2026-04-29
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.08 %
- ROE N/A %
- 52 Week High 82.81
- 52 Week Low 35.21
About
Cimpress plc offers various mass customization services in North America, Europe, and internationally. The company is headquartered in Dundalk, Ireland.
Analyst Target Price
$97.50
Quarterly Earnings
| Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-01-28 | 2025-10-29 | 2025-07-29 | 2025-04-30 | 2025-01-29 | 2024-10-30 | 2024-07-31 | 2024-05-02 | 2024-01-31 | 2023-10-25 | 2023-07-26 | 2023-04-27 |
| Reported EPS | 1.95 | 0.3 | -1.02 | -0.33 | 2.36 | -0.5 | 4.33 | -0.15 | 2.14 | 0.17 | 1.08 | -1.88 |
| Estimated EPS | 1.64 | 0.28 | 0.98 | 0.55 | 2.43 | 0.29 | 0.8 | 0.14 | 1.24 | -0.33 | 0.24 | -1.21 |
| Surprise | 0.31 | 0.02 | -2 | -0.88 | -0.07 | -0.79 | 3.53 | -0.29 | 0.9 | 0.5 | 0.84 | -0.67 |
| Surprise Percentage | 18.9024% | 7.1429% | -204.0816% | -160% | -2.8807% | -272.4138% | 441.25% | -207.1429% | 72.5806% | 151.5152% | 350% | -55.3719% |
Next Quarterly Earnings
| Mar 2026 | |
|---|---|
| Reported Date | 2026-04-29 |
| Fiscal Date Ending | 2026-03-31 |
| Estimated EPS | 0.15 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: CMPR
2026-04-16 22:39:35
Cimpress plc EVP Florian Baumgartner exercised 9,288 Restricted Share Units (RSUs) into ordinary shares as part of his equity compensation. From these, 4,411 shares were withheld at $80.49 per share to cover tax obligations. Following these transactions, Baumgartner directly holds 68,720 Cimpress ordinary shares, with the activity reflecting routine vesting and tax withholding rather than open-market trading.
2026-04-15 10:09:27
Cimpress plc (NASDAQ:CMPR) has received a consensus "Buy" rating from analysts, with an average 12-month price target of $97.50. Despite recent upgrades and price target increases from several firms, the company shows thin profitability with a 0.66% net margin and a high P/E ratio of 89.43, trading near its 52-week high around $80. Institutional investors have also been adjusting their positions in the stock.
2026-04-14 03:39:26
Cimpress plc has announced a US$200 million share repurchase program, leading to a 6.0% stock price increase. This move is significant for capital allocation but doesn't fundamentally alter the company's investment narrative, which still relies on converting earnings improvements into stronger free cash flow and managing high investment and debt levels. The buyback aligns with Cimpress' 2026 and 2028 financial targets, but investors must consider its leverage and ongoing investment needs.
2026-04-13 10:10:28
Zacks Investment Research highlights four stocks—BrightSpring Health Services, Aura Minerals, Constellium, and Cimpress—that demonstrate strong increasing cash flows, which is deemed a better indicator of financial health than profit alone, especially in uncertain economic times. The article explains that a healthy and growing cash flow enables companies to manage debt, reinvest, and withstand market disruptions. Each company's recent earnings revisions and VGM scores are noted, suggesting their potential for growth and resilience.
2026-04-08 11:00:00
Cimpress is focusing on leveraging cross-platform fulfillment and expanding its premium product offerings to enhance manufacturing efficiencies and capture a larger share of customer spending. Despite these strategic initiatives that could lead to medium-term value, the company faces near-term risks such as negative shareholders' equity and the impact of tariffs, leading to a "Hold" rating. These financial weaknesses and potential operational disruptions necessitate caution and justify a discounted valuation, even with a projected near-term upside.
2026-04-07 08:40:35
JPMorgan Chase & Co. has significantly increased its stake in Cimpress plc (NASDAQ:CMPR) by 77.8% during the third quarter, now holding 37,989 shares valued at $2.40 million. This makes up approximately 0.15% of the company. Cimpress, a mass customization and web-to-print services leader, recently reported strong quarterly earnings, surpassing analyst estimates with an EPS of $1.95 and revenue of $1.04 billion.
